NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 919 filers reported holding NOVARTIS A G in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $217,000 | -7.7% | 2,360 | -1.3% | 0.01% | 0.0% |
| Q2 2015 | $235,000 | +5.4% | 2,390 | +5.9% | 0.01% | +7.7% |
| Q1 2015 | $223,000 | +10.4% | 2,257 | +3.6% | 0.01% | 0.0% |
| Q4 2014 | $202,000 | -2.4% | 2,179 | -0.8% | 0.01% | -13.3% |
| Q3 2014 | $207,000 | -4.2% | 2,197 | -8.0% | 0.02% | -6.2% |
| Q2 2014 | $216,000 | -1.8% | 2,388 | -7.6% | 0.02% | -5.9% |
| Q1 2014 | $220,000 | +1.9% | 2,584 | -3.7% | 0.02% | -5.6% |
| Q4 2013 | $216,000 | +4.9% | 2,684 | 0.0% | 0.02% | -10.0% |
| Q3 2013 | $206,000 | -3.7% | 2,684 | -11.3% | 0.02% | -9.1% |
| Q2 2013 | $214,000 | -8.9% | 3,025 | -8.4% | 0.02% | -15.4% |
| Q1 2013 | $235,000 | -27.2% | 3,303 | -43.9% | 0.03% | -39.5% |
| Q2 2012 | $323,000 | -11.3% | 5,889 | -10.8% | 0.04% | -2.3% |
| Q1 2012 | $364,000 | +6.1% | 6,604 | +9.4% | 0.04% | -4.3% |
| Q4 2011 | $343,000 | -20.4% | 6,038 | -20.8% | 0.05% | -27.0% |
| Q3 2011 | $431,000 | – | 7,619 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |